News | April 16, 2024
Laurus Labs forms JV company
KRKA holds 51% and Laurus Labs holds 49% shareholding
KRKA holds 51% and Laurus Labs holds 49% shareholding
The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility
Uppilliappan joined Dr. Lal Pathlabs in 2016 as Chief Operating Officer and later became CEO
EDQM conducts GMP inspection of SMS Pharmaceuticals’ API facility
Clinical findings support the safety and efficacy of BMND08 at a maximum dosage of 12mg
Dr. Lal Path Labs has reported total income of Rs. 557.2 crores during the period ended December 31, 2023
Vimta Labs has reported total income of Rs. 82.57 crores during the period ended December 31, 2023
The registered capital of the newly founded company is € 50 million
Laurus Labs has reported total income of Rs. 1197.35 crores during the period ended December 31, 2023
The company disclosed that several employees of a subsidiary had their business email addresses stolen
Subscribe To Our Newsletter & Stay Updated
